Arrowhead Research Corp.

Home » Arrowhead Research Corp.

Secondary

Arrowhead Research Corp.

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes.

Symbol

ARWR

Last Closing Price
$5.72

Shares
7,000,000

Effective Date
January 18, 2018

Underwriters
Jefferies, Barclays, Cantor Fitzgerald

To view the prospectus for Arrowhead Research Corp., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253